Treatment of classical type kaposi's sarcoma with paclitaxel

S. C. Chao, J. Y.Y. Lee, C. J. Tsao

研究成果: Article同行評審

15 引文 斯高帕斯(Scopus)


Paclitaxel has recently been shown to be effective in treating acquired immunodeficiency syndrome-associated Kaposi's sarcoma. We report good therapeutic effects of paclitaxel in two patients with classical form Kaposi's sarcoma (KS) which had poor or partial response to chemotherapy (vincristine, vinblastine, oncovin, bleomycin, epirubicin, dactinomycin, decarbazine) and interferon alpha-2b. Paclitaxel appears to be active against Kaposi's sarcoma as a single agent. The experience suggests that paclitaxel is an effective alternative in the treatment of classical form Kaposi's sarcoma.

頁(從 - 到)571-574
期刊Anticancer research
發行號1 B
出版狀態Published - 2001 四月 17

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

指紋 深入研究「Treatment of classical type kaposi's sarcoma with paclitaxel」主題。共同形成了獨特的指紋。